WHO Maintains Global Health Emergency Status for Ebola Outbreak in DR Congo
(MENAFN) The Ebola outbreak in the Democratic Republic of Congo continues to qualify as a public health emergency of international concern, World Health Organization Director-General Tedros Adhanom Ghebreyesus announced Wednesday.
The decision came after the WHO Emergency Committee convened earlier that day to review the situation and evaluate the ongoing outbreak.
“We call for the cooperation of all governments and all partners to scale up the response further, and raise the resources needed to protect communities over the coming months,” Tedros said in a post on X.
He stressed the importance of safeguarding healthcare personnel, medical facilities and emergency response teams operating in affected areas, particularly as conflict continues to threaten communities.
Tedros added that revised guidance for the Democratic Republic of Congo and other countries would be released in the coming days.
During a WHO press briefing in Geneva on Tuesday, he reported that the outbreak had resulted in more than 11,300 infections and 5,500 deaths, while weekly new cases ranged between 400 and 500.
The organization also announced that two experimental vaccines specifically developed to target the Bundibugyo strain of the Ebola virus are expected to enter phase two clinical trials in Congo next week.
The decision came after the WHO Emergency Committee convened earlier that day to review the situation and evaluate the ongoing outbreak.
“We call for the cooperation of all governments and all partners to scale up the response further, and raise the resources needed to protect communities over the coming months,” Tedros said in a post on X.
He stressed the importance of safeguarding healthcare personnel, medical facilities and emergency response teams operating in affected areas, particularly as conflict continues to threaten communities.
Tedros added that revised guidance for the Democratic Republic of Congo and other countries would be released in the coming days.
During a WHO press briefing in Geneva on Tuesday, he reported that the outbreak had resulted in more than 11,300 infections and 5,500 deaths, while weekly new cases ranged between 400 and 500.
The organization also announced that two experimental vaccines specifically developed to target the Bundibugyo strain of the Ebola virus are expected to enter phase two clinical trials in Congo next week.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment